SOD1 and amyotrophic lateral sclerosis: Encouraged by the strong effect of RD2RD2 on neuroinflammation in treated APP/PS1 mice, we performed a treatment study using the transgenic ALS mouse model SOD1*G93A, a model in which neuroinflammation has been described to drive disease progression [18,19].